Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
According to Assura Plc's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.83. At the end of 2022 the company had a P/B ratio of 0.91.
Year | P/B ratio |
---|---|
2023 | 0.83 |
2022 | 0.91 |
2021 | 1.04 |
2020 | 1.25 |
2019 | 1.54 |
2018 | 1.07 |
2017 | 0.93 |
2016 | 1.16 |
2015 | 0.91 |
2014 | 1.05 |
2013 | 0.95 |
2012 | 0.89 |
2011 | 0.72 |
2010 | 0.61 |
2009 | 0.84 |
2008 | 0.33 |
2007 | 9.56 |
2006 | 1.42 |
2005 | 2.09 |
2004 | 1.10 |